Pfizer Ltd
NSE:PFIZER

Watchlist Manager
Pfizer Ltd Logo
Pfizer Ltd
NSE:PFIZER
Watchlist
Price: 5 206.95 INR -0.02% Market Closed
Market Cap: 238.2B INR
Have any thoughts about
Pfizer Ltd?
Write Note

Pfizer Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pfizer Ltd
Cash Equivalents Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Pfizer Ltd
NSE:PFIZER
Cash Equivalents
â‚ą22.8B
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
21%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Equivalents
â‚ą7.1B
CAGR 3-Years
-22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Equivalents
â‚ą9.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Equivalents
â‚ą90.2B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Equivalents
â‚ą11.5B
CAGR 3-Years
49%
CAGR 5-Years
14%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Cash Equivalents
â‚ą1.2B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pfizer Ltd's Cash Equivalents?
Cash Equivalents
22.8B INR

Based on the financial report for Sep 30, 2024, Pfizer Ltd's Cash Equivalents amounts to 22.8B INR.

What is Pfizer Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
21%

Over the last year, the Cash Equivalents growth was 21%. The average annual Cash Equivalents growth rates for Pfizer Ltd have been 15% over the past three years , 2% over the past five years , and 21% over the past ten years .

Back to Top